Viewing Study NCT00034502


Ignite Creation Date: 2025-12-25 @ 3:52 AM
Ignite Modification Date: 2025-12-26 @ 2:41 AM
Study NCT ID: NCT00034502
Status: COMPLETED
Last Update Posted: 2006-07-19
First Post: 2002-04-29
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Trial of ALIMTA (Pemetrexed) Plus Irinotecan in Patients Who Have Been Previously Treated For Metastatic Colorectal Cancer.
Sponsor: Eli Lilly and Company
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: None
Start Date Type: None
Primary Completion Date: None
Primary Completion Date Type: None
Completion Date: None
Completion Date Type: None
First Submit Date: 2002-04-29
First Submit QC Date: None
Study First Post Date: 2002-04-30
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2006-07-18
Last Update Post Date: 2006-07-19
Last Update Post Date Type: ESTIMATED